Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Perry

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|June 11, 2024
Clinical consensus on treatments for transplant-ineligible newly diagnosed multiple myeloma: double-blinded Delphi panelRafael Fonseca, Adriana Rossi, Rohan Medhekar, et al.
BMJ Open|January 30, 2026
Stroke Investigation Group in North and Central London (SIGNAL): cohort profile of a prospective large-scale comprehensive stroke registryHatice Ozkan, Gareth Ambler, Philip S Nash, et al.
Toxicologic Pathology|December 13, 2006
Best practices for reporting pathology interpretations within GLP toxicology studiesDaniel Morton, Ramon K Kemp, Sabine Francke-Carroll, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 15, 2024
Alzheimer's disease heterogeneity revealed by neuroanatomical normative modelingFlavia Loreto, Serena Verdi, Seyed Mostafa Kia, et al.
Journal of the American Association of Nurse Practitioners|December 19, 2025
Expert consensus on patient engagement strategies for improving patient activation and shared decision making in pulmonary arterial hypertensionJohn J Ryan, Melisa Wilson, Rajan Saggar, et al.
The Journal of Prevention of Alzheimer'S Disease|February 14, 2026
Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotesRichard Perry, Christopher Kipps, Maria Eugenia Soto Martín, et al.
The Journal of Prevention of Alzheimer'S Disease|March 14, 2026
Corrigendum to "Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes" [The Journal of Prevention of Alzheimer's Disease (2026) 100507]Richard Perry, Christopher Kipps, Maria Eugenia Soto Martín, et al.
European Stroke Journal|January 23, 2025
Risk factors, mechanisms, and clinical outcomes of stroke in young adults presenting to a North Central London stroke service: UCL Young Stroke Systematic Evaluation Study (ULYSSES)Raafiah Mussa, Gareth Ambler, Hatice Ozkan, et al.
Journal of Nephrology|October 24, 2025
A European Delphi study on the management of anaemia of CKD: unmet needs in personalized treatmentIndranil Dasgupta, Roberto Minutolo, Samira Bell, et al.
Pulmonary Circulation|June 10, 2025
The Role of Telehealth in PAH Management: Benefits, Barriers, and SolutionsSusanne McDevitt, Martha Kingman, Lana Melendres Groves, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|June 11, 2024
Clinical consensus on treatments for transplant-ineligible newly diagnosed multiple myeloma: double-blinded Delphi panelRafael Fonseca, Adriana Rossi, Rohan Medhekar, et al.
BMJ Open|January 30, 2026
Stroke Investigation Group in North and Central London (SIGNAL): cohort profile of a prospective large-scale comprehensive stroke registryHatice Ozkan, Gareth Ambler, Philip S Nash, et al.
Toxicologic Pathology|December 13, 2006
Best practices for reporting pathology interpretations within GLP toxicology studiesDaniel Morton, Ramon K Kemp, Sabine Francke-Carroll, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 15, 2024
Alzheimer's disease heterogeneity revealed by neuroanatomical normative modelingFlavia Loreto, Serena Verdi, Seyed Mostafa Kia, et al.
Journal of the American Association of Nurse Practitioners|December 19, 2025
Expert consensus on patient engagement strategies for improving patient activation and shared decision making in pulmonary arterial hypertensionJohn J Ryan, Melisa Wilson, Rajan Saggar, et al.
The Journal of Prevention of Alzheimer'S Disease|February 14, 2026
Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotesRichard Perry, Christopher Kipps, Maria Eugenia Soto Martín, et al.
The Journal of Prevention of Alzheimer'S Disease|March 14, 2026
Corrigendum to "Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes" [The Journal of Prevention of Alzheimer's Disease (2026) 100507]Richard Perry, Christopher Kipps, Maria Eugenia Soto Martín, et al.
European Stroke Journal|January 23, 2025
Risk factors, mechanisms, and clinical outcomes of stroke in young adults presenting to a North Central London stroke service: UCL Young Stroke Systematic Evaluation Study (ULYSSES)Raafiah Mussa, Gareth Ambler, Hatice Ozkan, et al.
Journal of Nephrology|October 24, 2025
A European Delphi study on the management of anaemia of CKD: unmet needs in personalized treatmentIndranil Dasgupta, Roberto Minutolo, Samira Bell, et al.
Pulmonary Circulation|June 10, 2025
The Role of Telehealth in PAH Management: Benefits, Barriers, and SolutionsSusanne McDevitt, Martha Kingman, Lana Melendres Groves, et al.
Pageof 9